Genworth Financial INC Stock: price and insider trades · United States · SEC (Form 4)Track the Genworth Financial INC share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Banks sector, Genworth Financial INC has published 115 reports. Market capitalisation: €3.8bn. The latest transaction was reported on 8 September 2026 (Cession). Among the most active insiders: McInerney Thomas J. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,442 of 29,063 companies
FCF yld 8.7%
Earn yld 5.9%
EV/EBITDA 10.2x
ROE 3.4%
Gross mgn ·
Net mgn 3.1%
Debt/EBITDA 2.9x
Pillars 2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 September 2026
All Executives115 Thresholds0 Prospectus0 Other0
Declarations 115 total
▼ President and CEO; Director · Executives · 3 Sept 2026
100,000 shares @ US$10.526 Common Stock SEC:0001321272-26-000009:0
● Officer, Director · Executives · 3 Sept 2026
100,000 shares @ US$10.5259 0.028% mcap 11.3% of flow Common SEC144:0001959173-26-006703
● EVP and Chief HR Officer · Executives · 24 Aug 2026
11,000 shares 0Common Stock SEC:0001899394-26-000008:1
▼ EVP and Chief HR Officer · Executives · 24 Aug 2026
14,708 shares @ US$9.915 Common Stock SEC:0001899394-26-000008:0
● Officer · Executives · 24 Aug 2026
14,708 shares @ US$9.915 0.0039% mcap 100.0% of flow Common SEC144:0001959173-26-006378
▼ EVP and General Counsel · Executives · 21 Aug 2026
40,000 shares @ US$9.9118 0.011% mcap 100.0% of flow Common Stock SEC:0001899392-26-000008:0
● President and CEO; Director · Executives · 27 May 2026
200,000 shares 0Common Stock SEC:0001321272-26-000007:0
▼ President and CEO; Director · Executives · 22 May 2026
100,000 shares @ US$9.27 0.023% mcap 10.4% of flow Common Stock SEC:0001321272-26-000005:0
◆ Director · Executives · 20 May 2026
18,264 shares @ US$9.0345 0.0041% mcap 25.1% of flow Common Stock SEC:0001573094-26-000002:0
◆ Director · Executives · 20 May 2026
18,264 shares @ US$9.0345 0.0041% mcap 25.1% of flow Common Stock SEC:0001835315-26-000002:0
◆ Director · Executives · 20 May 2026
31,547 shares @ US$9.0345 0.0071% mcap 24.6% of flow Common Stock SEC:0001162304-26-000002:0
◆ Director · Executives · 20 May 2026
18,264 shares @ US$9.0345 0.0041% mcap 19.2% of flow Common Stock SEC:0001227758-26-000004:0
◆ Director · Executives · 20 May 2026
18,264 shares @ US$9.0345 0.0041% mcap 25.1% of flow Common Stock SEC:0001551825-26-000003:0
◆ Director · Executives · 20 May 2026
32,100 shares @ US$9.0345 0.0072% mcap 20.3% of flow Common Stock SEC:0001552249-26-000002:0
◆ Director · Executives · 20 May 2026
32,100 shares @ US$9.0345 0.0072% mcap 91.5% of flow Common Stock SEC:0001569219-26-000002:0
◆ Director · Executives · 20 May 2026
18,264 shares @ US$9.0345 0.0041% mcap 25.1% of flow Common Stock SEC:0001852739-26-000002:0
◆ Director · Executives · 20 May 2026
18,264 shares @ US$9.0345 0.0041% mcap 25.1% of flow Common Stock SEC:0001853248-26-000002:0
◆ Director · Executives · 22 May 2025
23,681.378 shares @ US$6.9675 19.8% of flow Common Stock SEC:0000950170-25-076968:0
◆ Director · Executives · 22 May 2025
23,681.378 shares @ US$6.9675 25.8% of flow Common Stock SEC:0000950170-25-076967:0
◆ Director · Executives · 21 May 2025
3,954.067 shares @ US$6.67 8.5% of flow Common Stock SEC:0000950170-25-076973:0
◆ Director · Executives · 22 May 2025
23,681.378 shares @ US$6.9675 25.8% of flow Common Stock SEC:0000950170-25-076961:0
◆ Director · Executives · 22 May 2025
23,681.378 shares @ US$6.9675 25.8% of flow Common Stock SEC:0000950170-25-076962:0
◆ Director · Executives · 22 May 2025
23,681.378 shares @ US$6.9675 25.8% of flow Common Stock SEC:0000950170-25-076972:0
◆ Director · Executives · 22 May 2025
23,681.378 shares @ US$6.9675 25.8% of flow Common Stock SEC:0000950170-25-076963:0
◆ Director · Executives · 22 May 2025
41,621.816 shares @ US$6.9675 21.0% of flow Common Stock SEC:0000950170-25-076970:0
25 of 115 declarations
Load more (90 remaining) 关于 Genworth Financial INC Genworth Financial Inc. (NYSE: GNW) 是一家在美国弗吉尼亚州里士满设有总部的美国上市公司。对于国际股票投资者而言,它最好被视为一家专业保险公司,而非一家广泛多元化的金融集团。Genworth目前的投资案例以长期护理保险专业知识、通过其受控子公司Enact Holdings持有的抵押贷款保险股权,以及在CareScout品牌下新兴的老年护理服务平台为核心。该公司的投资者材料和备案文件强调帮助家庭应对护理决策、资助长期护理需求以及规划老龄化的财务现实。([investor.genworth.com](https://investor.genworth.com/company-information))
该公司的历史可追溯到1871年,当时其前身业务始于弗吉尼亚人寿保险公司。随着时间的推移,Genworth通过传统寿险、年金和保障业务发展,最终成为如今独立的金融服务公司。悠久的运营历史很重要:它赋予公司品牌长寿和深厚的保险专业知识,但也使Genworth拥有庞大的传统业务组合,这继续影响着收益、准备金和资本管理。([groupva.genworth.com](https://groupva.genworth.com/groupva/tmc/publicjsp/jsp_About.do?utm_source=openai))
Genworth通过三个运营部门报告:Enact;长期护理保险;以及寿险和年金。Enact是通过Enact Holdings运营的美国私人抵押贷款保险业务,Enact Holdings在纳斯达克单独上市,股票代码为ACT,但仍是Genworth的合并子公司。长期护理保险部门涵盖公司在美国的传统长期护理保险组合和相关的在保管理行动。寿险和年金部门包括已停止积极销售的寿险和年金产品的封闭业务。此外,Genworth正在建立CareScout,这是一家初创公司式的业务,专注于基于费用的服务、咨询、顾问和其他老年护理产品和服务。([sec.gov](https://www.sec.gov/Archives/edgar/data/1276520/000119312525041860/d869080d10k.htm))
从竞争角度来看,Genworth是一家利基市场参与者,拥有独特的收益来源组合。Enact使该集团能够接触美国抵押贷款保险市场,其中私人抵押贷款保险仍与住房发放量和信贷趋势相关。长期护理特许经营权更为专业化:它不是一个大众市场增长引擎,而是一个复杂的投资组合,其中定价、准备金充足性和监管批准至关重要。这使得Genworth更像是一家具有资本配置故事的专业保险公司,而不是一家传统的增长型保险公司。([sec.gov](https://www.sec.gov/Archives/edgar/data/1276520/000119312525041860/d869080d10k.htm))
最新消息显示持续的战略执行。2025年,Genworth强调了来自Enact的资本回报、其长期护理保单多年在保费率行动计划的持续进展,以及对CareScout的进一步投资。一个值得注意的事件是CareScout收购了Seniorly,一个老年生活平台和顾问网络,该收购于2025年完成,并被视为加强直接面向消费者能力和拓宽公司老年护理生态系统的方式。Genworth还报告了其CareScout质量网络的持续扩张以及新的产品和服务举措,这强化了管理层在传统保险业务之外建立未来增长的努力。([investor.genworth.com](https://investor.genworth.com/news-events/press-releases/detail/1049/carescout-completes-acquisition-of-seniorly?utm_source=openai))